
PHQ-9 Scoring and Interpretation
This page covers how to score and interpret the Patient Health Questionnaire-9 (PHQ-9). For an overview of what the scale measures and how to administer it in Labvanced, see the PHQ-9 instrument page.
Table of Contents
Scoring Procedure for the PHQ-9
Each of the 9 items is scored by assigning 0, 1, 2, and 3 to "Not at all," "Several days," "More than half the days," and "Nearly every day." The item scores are summed into a total from 0 to 27 (Pfizer, n.d.). See the Sum Scoring guide for how this calculation is set up in Labvanced.
In the Labvanced study, the matrix stores each selection as 1 to 4, so each item score is the stored value minus 1.
Reverse-Scored Items
None. All 9 items are scored in the same direction.
The Difficulty Question
The final question, on how difficult these problems have made daily life, is not used in calculating any score (Pfizer, n.d.). The Labvanced study records it separately as Item 10.
Severity Score and Diagnostic Algorithm
The PHQ-9 can also be scored with a separate algorithm for provisional diagnoses. Major depressive syndrome requires five or more of the 9 items at "More than half the days" or above, with item 1 or item 2 among them and item 9 counted if present at all (Pfizer, n.d.). The manual adds that a diagnosis requires ruling out normal bereavement, a history of a manic episode, and a physical disorder, medication, or other drug as the cause. The Labvanced study calculates the severity score only.
Cutoff Scores and Severity Bands for the PHQ-9
| Severity | Score Range |
|---|---|
| Minimal | 0-4 |
| Mild | 5-9 |
| Moderate | 10-14 |
| Moderately severe | 15-19 |
| Severe | 20-27 |
Cutoff scheme: Kroenke et al. (2001), who chose these points partly because they are simple for clinicians to remember and apply. The manual labels the lowest band "None-minimal" (Pfizer, n.d.).
A score of 10 or above is also used as a screening threshold for major depression. It is separate from the severity bands, which describe symptom level. In an individual participant data meta-analysis, this cutoff had a sensitivity of .88 and specificity of .85 against semistructured interviews, but a sensitivity of .70 against fully structured interviews (Levis et al., 2019). An earlier meta-analysis found no substantial differences in pooled sensitivity and specificity across cutoffs from 8 to 11 (Manea et al., 2012).
Interpreting Your Score on the PHQ-9
A higher total score indicates more frequent depression symptoms over the last 2 weeks. Because the PHQ-9 produces a single total, there is no subscale interpretation to consider.
A score of 10 or above does not mean a person has major depression. Levis et al. (2019) calculated that, with major depression at 14% prevalence, only 49% of positive screens at this cutoff would be true positives.
Item 9
Read item 9 on its own as well as within the total, because a person can endorse it with a low total score. The manual states that a final decision about the actual risk of self-harm requires a clinical interview (Pfizer, n.d.). In 84,418 outpatients, cumulative one-year risk of a suicide attempt rose from .4% among those answering "Not at all" to 4% among those answering "Nearly every day" (Simon et al., 2013). A study using the PHQ-9 should decide in advance who reviews item 9 responses and how participants will be supported.
The PHQ-9 is a screening and severity measure, not a diagnostic instrument. A score in the Moderate range or above, or a total score of 10 or greater, indicates elevated likelihood of major depression, but does not on its own constitute a diagnosis. Interpretation should be made in the context of a full clinical evaluation by a qualified professional.
Reliability and Validity of the PHQ-9 (Extended)
Beyond the primary summary on the instrument page, further findings extend the evidence base for the PHQ-9:
- Test-retest reliability and sensitivity to change: When the PHQ-9 was completed twice exactly 7 days apart in a late-life depression trial, test-retest reliability was reported as excellent. Its responsiveness to treatment was greater than the SCL-20 at 3 months and equivalent at 6 months (Löwe et al., 2004).
- Reference standard effects: Across cutoffs from 5 to 15, sensitivity was 5-22% higher against semistructured interviews than against fully structured interviews, excluding the MINI, and 2-15% higher than against the MINI (Levis et al., 2019). A published accuracy figure therefore depends partly on the interview used as the comparison.
- Age: The PHQ-9 seemed similarly sensitive across age groups but may be less specific for younger patients, and a cutoff of 10 or above could be used regardless of age (Levis et al., 2019).
- Cross-cultural comparison: In online samples of Chinese and German students, the PHQ-9 showed partial scalar measurement invariance (Zhou et al., 2020).
See the PHQ-9 instrument page for the primary reliability and validity summary.
Related Resources
PHQ-9 Instrument Page
What the scale measures, item structure, and how to deploy it in Labvanced.
Questionnaires in Labvanced
Deploy validated self-report instruments with automatic scoring and no-code setup.
References
- Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
- Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ, 365, l1476. https://doi.org/10.1136/bmj.l1476
- Löwe, B., Unützer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Medical Care, 42(12), 1194-1201. https://doi.org/10.1097/00005650-200412000-00006
- Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. CMAJ, 184(3), E191-E196. https://doi.org/10.1503/cmaj.110829
- Pfizer. (n.d.). Instruction manual: Instructions for Patient Health Questionnaire (PHQ) and GAD-7 measures. Retrieved November 4, 2026, from https://www.phqscreeners.com/images/sites/g/files/g10016261/f/201412/instructions.pdf
- Simon, G. E., Rutter, C. M., Peterson, D., Oliver, M., Whiteside, U., Operskalski, B., & Ludman, E. J. (2013). Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death? Psychiatric Services, 64(12), 1195-1202. https://doi.org/10.1176/appi.ps.201200587
- Zhou, Y., Xu, J., & Rief, W. (2020). Are comparisons of mental disorders between Chinese and German students possible? An examination of measurement invariance for the PHQ-15, PHQ-9 and GAD-7. BMC Psychiatry, 20(1), 480. https://doi.org/10.1186/s12888-020-02859-8